These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15364883)

  • 1. Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
    Span PN; Sweep FC; Wiegerinck ET; Tjan-Heijnen VC; Manders P; Beex LV; de Kok JB
    Clin Chem; 2004 Nov; 50(11):1986-93. PubMed ID: 15364883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
    Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
    Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
    Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
    Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and significance of survivin mRNA in urinary bladder carcinomas.
    Wang H; Xi X; Kong X; Huang G; Ge G
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
    O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
    Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
    Kostadima L; Pentheroudakis G; Fountzilas G; Dimopoulos M; Pectasides D; Gogas H; Stropp U; Christodoulou C; Samantas E; Wirtz R; Hennig G; Bafaloukos D; Arapantoni P; Kalofonos H; Papakostas P; Economopoulos T; Bamias A; Pavlidis N
    Breast Cancer Res Treat; 2006 Nov; 100(2):161-7. PubMed ID: 16823513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
    Hinnis AR; Luckett JC; Walker RA
    Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
    Nassar A; Lawson D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.
    Monzó M; Rosell R; Felip E; Astudillo J; Sánchez JJ; Maestre J; Martín C; Font A; Barnadas A; Abad A
    J Clin Oncol; 1999 Jul; 17(7):2100-4. PubMed ID: 10561264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.
    Schultz IJ; Kiemeney LA; Karthaus HF; Witjes JA; Willems JL; Swinkels DW; Gunnewiek JM; de Kok JB
    Clin Chem; 2004 Aug; 50(8):1425-8. PubMed ID: 15277352
    [No Abstract]   [Full Text] [Related]  

  • 17. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
    Takeuchi H; Morton DL; Elashoff D; Hoon DS
    Int J Cancer; 2005 Dec; 117(6):1032-8. PubMed ID: 15986442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
    Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
    Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
    Ghadersohi A; Odunsi K; Zhang S; Azrak RG; Bundy BN; Manjili MH; Li F
    Int J Cancer; 2008 Sep; 123(6):1376-84. PubMed ID: 18567002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
    Ponnelle T; Chapusot C; Martin L; Bouvier AM; Plenchette S; Faivre J; Solary E; Piard F
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):504-10. PubMed ID: 15902487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.